The DOI matches its Crossref record.
Frontiers in Bioengineering and Biotechnology
Open accessAbstract
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application. Frontiers in Bioengineering and Biotechnology is a member of the Committee on Publication Ethics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Reproducible molecular networking of untargeted mass spectrometry data using GNPS
Aron, A. T., Gentry, E. C., McPhail, K. L., Nothias, L.-F., Nothias-Esposito, M., Bouslimani, A., Petras, D., Gauglitz, J. M., Sikora, N., Vargas, F., et al. (2020) · Nature Protocols · doi:10.1038/s41596-020-0317-5 · Cited by 725
Lee, C., Kim, M., Kim, Y. J., Hong, N., Ryu, S., Kim, H. J., & Kim, S. (2017) · International Journal of Control, Automation and Systems · doi:10.1007/s12555-016-0462-3 · Cited by 616
Review of recent developments in GC–MS approaches to metabolomics-based research
Beale, D. J., Pinu, F. R., Kouremenos, K. A., Poojary, M. M., Narayana, V. K., Boughton, B. A., Kanojia, K., Dayalan, S., Jones, O. A. H., & Dias, D. A. (2018) · Metabolomics · doi:10.1007/s11306-018-1449-2 · Cited by 531
Cheah, Y. T., & Chan, D. J. C. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15455 · Cited by 108
Enhancing the Bio-Prospective of Microalgae by Different Light Systems and Photoperiods
Parveen, A., Bhatnagar, P., Gautam, P., Bisht, B., Nanda, M., Kumar, S., Vlaskin, M. S., & Kumar, V. (2023) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-023-00471-9 · Cited by 44
Metadata
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2021-03-02
- ISSN
- 2296-4185 (ISSN-L)
- OpenAlex
- W4241671229
- Cited by
- 1,092
- References
- 0
- Type
- paratext
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Frontiers in Bioengineering and Biotechnology. https://app.cochat.ai/papers/10.3389/fbioe
- The paper
- Frontiers in Bioengineering and Biotechnology. (2021). Frontiers in Bioengineering and Biotechnology. https://doi.org/10.3389/fbioe
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.